Application | Comment | Organism |
---|---|---|
medicine | transient inhibition of BHMT in vivo causes transient hyperhomocysteinemia | Mus musculus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
S-(delta-Carboxybutyl)-DL-homocysteine | 0.005 mM reduces BHMT activity ca. 95% in the standard assay that contains high levels (0.0025 mM) of L-homocysteine. Compared with saline-injected control mice, at 2 h postinjection, mice have 87% lower BHMT activity and a 2.7fold increase in plasma total homocysteine, effects that last nearly 8 h but return to normal by 24 h, level of BHMT protein remains constant over the 24-h period. After 6 injections (one every 12 h), the mice have 7fold higher plasma total homocysteine, a 65% reduction in the liver S-adenosylmethionine: S-adenosylhomocysteine ratio, and a marked upregulation of BHMT protein expression. When methionine is injected, postmethionine load plasma total homocysteine levels are 2.2fold higher at 2 h postinjection | Mus musculus | |
S-(delta-carboxybutyl)-DL-homocysteine-sulfoxide | at 2 h after injection, there is a modest reduction in BHMT activity and a 90% increase in plasma total homocysteine | Mus musculus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
6-week-old Balb/C male mice | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | - |
Mus musculus | - |
Synonyms | Comment | Organism |
---|---|---|
BHMT | - |
Mus musculus |